news

Pfizer Covid-19 vaccine gets conditional approval as booster dose - Health DG

KUALA LUMPUR (Oct 8): The Health Ministry has granted conditional approval for the Comirnaty vaccine to be used as a booster shot at least six months after the second dose for those aged 18 and above.

Health director-general Tan Sri Dr Noor Hisham Abdullah said the matter was decided during the 365th Drug Control Authority (DCA) meeting today.

"The Comirnaty vaccine produced by Pfizer Manufacturing Belgium NV (Belgium) and BioNTech Manufacturing GmbH, Germany was earlier approved for conditional registration on June 15 for individuals aged 12 and above.

"This is the first Covid-19 vaccine approved as a booster dose in the country,” he said in a statement.

Dr Noor Hisham said the approval of the conditional registration required information on the quality, safety and effectiveness of the vaccine to be monitored and evaluated based on the latest data from time to time to ensure that the benefit over risk comparison remained positive.

"The ministry is always committed in improving access to COVID-19 vaccine products in Malaysia by ensuring that they have been evaluated in terms of quality, safety and effectiveness by the National Pharmaceutical Regulatory Agency (NPRA) and approved by DCA,” he added.

Get the latest news @ www.EdgeProp.my

Subscribe to our Telegram channel for the latest stories and updates 

Click here for more property stories

Looking for properties to buy or rent? With >150,000 exclusive listings, including undervalued properties, from vetted Pro Agents, you can now easily find the right property on Malaysia's leading property portal EdgeProp! You can also get free past transacted data and use our proprietary Edge Reference Price tool, to make an informed purchase.
SHARE
RELATED POSTS
  1. Covid-19: 96.1% of adult population fully vaccinated on Nov 27
  2. Covid-19: 95.9% of adult population in Malaysia fully vaccinated as of Nov 25
  3. Sinovac vaccine efficacy drops to 28% in three to five months — report